Prospective Study of Chemotherapy Induced Peripheral Neuropathy
Prospective Study of Chemotherapy-Induced Peripheral Neuropathy
Sponsor: Thompson Family Foundation
Enrolling: Male and Female Patients
IRB Number: AAAP4050
Contact: Raisy Fayerman, CRC: 212-305-6035 / rf2632@cumc.columbia.edu
Additional Study Information: The primary purpose of this research study is to better understand what causes chemotherapy-induced peripheral neuropathy. Chemotherapy-induced peripheral neuropathy is a numbness, tingling, or pain caused by chemotherapy. It can interfere with activities of daily life and quality of life to different degrees.
This study is closed
Investigator
Thomas Brannagan, MD
Do You Qualify?
Have you been diagnosed with gastrointestinal, gynecologic cancer, or breast cancer? Yes No
Have you received chemotherapy or biologic agent in the past 365 days? Yes No
Are you planning to receive a taxane or platinum-based chemotherapy? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Raisy Fayerman, CRC
rf2632@cumc.columbia.edu
212-305-6035
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE